CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial. [electronic resource]
Producer: 20000201Description: 1079-86 p. digitalISSN:- 0923-7534
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bleomycin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Multivariate Analysis
- Prednisolone -- administration & dosage
- Prognosis
- Quality of Life
- Survival Rate
- Time Factors
- Treatment Failure
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.